Literature DB >> 12010506

Matrix metalloproteinases and their inhibitors in acute viral hepatitis.

M Koulentaki1, V Valatas, K Xidakis, A Kouroumalis, E Petinaki, E Castanas, E Kouroumalis.   

Abstract

Matrix metalloproteases (MMPs) and their inhibitors are effector molecules involved in extracellular matrix remodelling. The serum profile for these proteolytic enzymes and their inhibitors during acute self-limiting viral hepatitis has not been studied. We therefore determined serum concentrations of MMP-1, MMP-3, MMP-2, MMP-9 and their inhibitors (tissue inhibitors of metalloproteinase) TIMP-1, TIMP-2 and alpha2 macroglobulin (AMG) in the serum of patients during the icteric stage of self-limiting acute viral hepatitis. Transforming growth factor-beta (TGF-beta) and interleukin (IL)-10, two cytokines involved in the regulation of MMPs and TIMPs were also assessed. Nineteen patients (12 men, seven women) with a mean age of 29.9 years (range 16-65 years) participated in the study. Fifteen had hepatitis B virus (HBV, two HCV and two HAV infection. The values of patients were compared with those obtained from 15 blood donor controls (eight men, seven women), mean age 36.2 years (range 18-55 years). Serum levels of TGF-beta, IL-10, MMP-1, MMP-3, MMP-2, MMP-9, TIMP-1 and TIMP-2 were assessed by ELISA. MMP-2 and MMP-9 were also measured by a zymogram protease assay. alpha2 macroglobulin (AMG) was measured by nephelometry. Compared with the healthy controls the mean serum concentrations of all MMPs were significantly decreased in the acute hepatitis patients. There was no difference in the serum concentration of TIMP-1 between patients and the controls. Serum levels of TIMP-2 (P < 0001), TGF-beta (P < 0.05), IL-10 (P < 0.001) and AMG (P < 0001) were increased in patients compared to healthy controls. A statistically significant negative correlation by linear regression analysis was found between AMG and MMP-1 (P=0003). The decreased levels of MMPs observed, together with normal and increased levels of TIMP-1 and TIMP-2, may indicate an attempt to limit matrix degradation at this stage of disease resolution. The increased levels of the anti-inflammatory cytokines IL-10 and TGF-beta might be the underlying mechanism responsible for the above effect. AMG inhibition especially for MMP-1 may play an additional important role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010506     DOI: 10.1046/j.1365-2893.2002.00351.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  3 in total

1.  Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B.

Authors:  James Fung; Ching-Lung Lai; David But; Axel Hsu; Wai-Kay Seto; Charles Cheng; Danny Ka-Ho Wong; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2010-07-24       Impact factor: 6.047

2.  Altered circulating levels of matrix metalloproteinases and inhibitors associated with elevated type 2 cytokines in lymphatic filarial disease.

Authors:  Rajamanickam Anuradha; Jovvian P George; Nathella Pavankumar; Vasanthapuram Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  PLoS Negl Trop Dis       Date:  2012-06-05

3.  TGF-β1 gene - 509C > T promoter polymorphism modulates TGF-β1 levels in hepatitis E patients.

Authors:  Sanjay B Rathod; Anuradha S Tripathy
Journal:  Meta Gene       Date:  2015-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.